Skip to main content
. 2008 Nov 2;7:229. doi: 10.1186/1475-2875-7-229

Figure 3.

Figure 3

Delay in the spread of resistance to SP. The delay in the development of resistance is measured as the proportional increase in time to 50% resistance compared to the continued use of SP as a monotherapy.